Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Research into Oral Semaglutide and Heart Failure Outcomes
February 2026
The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.
Read more
9
Mins
22 Mar 2022
ST Elevation Myocardial Infarction in Patients with COVID-19: Case Series
Patients with COVID 19 with associated myocardial infarction and myocarditis, requiring myocarditis treatment…
3
Mins
21 Mar 2022
Undiagnosed Hidradenitis Suppurativa Associated with Acute Myocardial Infarction: A Case Report
Hidradenitis Suppurativa (HS) is a chronic inflammatory disease believed to be a risk factor for cardiovascular events…
4
Mins
21 Feb 2022
Idarucizumab in Emergent Pericardiocentesis
A 71-year-old male with atrial fibrillation (AF) was admitted to the authors’ emergency department with fever, progressive dyspnoea…
24 Jan 2022
Outlining the 2021 ESC Guidelines for the Management of Valvular Heart Disease
Valvular heart disease (VHD) is a common condition characterised by damage or a defect in one or more of the four heart valves…
21 Jan 2022
Prescribing Aspirin Based on the Benefit-to-Risk Ratio
The American Heart Association and American College of Cardiology have restricted the use of aspirin in cardiovascular disease prevention to people under 70…
21 Jan 2022
Identifying Patients with Graves’ Disease at High-Risk for Atrial Fibrillation
Hyperthyroidism is associated with atrial fibrillation and heart failure, two conditions that can cause morbidity and mortality…
5
Mins
20 Dec 2021
Clinical Efficiency of Absolute Quantitative Cardiovascular Magnetic Resonance Myocardial Perfusion for Coronary Artery Disease
Myocardial perfusion can be performed using several different methods. In clinical practice, robust techniques include single photon…
5
Mins
9 Dec 2021
Aficamten: A New Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy
REDWOOD-HCM was a multicentre, randomised, placebo-controlled, double-blind, dose-finding clinical trial of aficamten in patients with symptomatic oHCM on background medical therapy.
Loading posts...
« Previous
1
…
47
48
49
50
51
…
96
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View